Researchers take advantage of MBL International’s recombinant IL-18 to activate varying cells like peripheral blood cells, macrophages, NK cells and T cells to identify targets.
IL-18 Therapies Targeting Inflammatory Disease
MBL International offers a wide variety of products to help in the research of IL-18.